Northcape Wealth Management LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 89.6% during the second quarter, Holdings Channel.com reports. The firm owned 8,347 shares of the healthcare conglomerate’s stock after buying an additional 3,944 shares during the period. Northcape Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,604,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Caitlin John LLC increased its position in shares of UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after acquiring an additional 111 shares during the period. Murphy Pohlad Asset Management LLC increased its position in shares of UnitedHealth Group by 21.8% in the 2nd quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock valued at $1,380,000 after acquiring an additional 791 shares during the period. Triumph Capital Management acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $1,324,000. Wealth Effects LLC increased its position in shares of UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after acquiring an additional 591 shares during the period. Finally, Arlington Partners LLC purchased a new position in shares of UnitedHealth Group during the second quarter worth $2,229,000. 87.86% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on UNH. Sanford C. Bernstein raised their target price on shares of UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Jefferies Financial Group raised their target price on shares of UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a report on Friday, October 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Bank of America raised their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday, October 8th. Finally, Oppenheimer cut their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $397.12.
UnitedHealth Group Stock Down 2.3%
Shares of NYSE UNH opened at $333.87 on Tuesday. The company’s 50-day simple moving average is $344.08 and its 200-day simple moving average is $324.95. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The firm has a market cap of $302.43 billion, a price-to-earnings ratio of 17.43, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same quarter last year, the business earned $7.15 earnings per share. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s payout ratio is presently 46.14%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- The Risks of Owning Bonds
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- What is a Death Cross in Stocks?
- The Best Local Butchers for Thanksgiving [2025 Survey]
- What Are Some of the Best Large-Cap Stocks to Buy?
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
